A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC

Clinical trial NCT02860546 · COMPLETED

Trial details

NCT number: NCT02860546
Sponsor: Taiho Oncology, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Refractory Metastatic Colorectal Cancer

Start date: 2016-08-29
Primary completion: 2017-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.